CMS Issues Guidance for SARS-CoV-2 Point-of-Care Tests and CLIA Certificates of Waiver

COLA is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our COLA laboratories and affiliates. Below is a link to the most recent message about CMS guidance for SARS-CoV-2 point-of-care tests and CLIA Certificates of Waiver.

CMS Issues Guidance for SARS-CoV-2 Point-of-Care Tests and CLIA Certificates of Waiver

On December 14, 2020, the Centers for Medicare & Medicaid Services (CMS) posted a question and answer (Q&A) document that provides guidance on the temporary enforcement discretion for any facility that has applied for a Clinical Laboratory Improvement Amendments (CLIA) Certificate of Waiver (CoW) to perform SARS-CoV-2 point-of-care (POC) testing, but has not yet been assigned a CLIA number